The present disclosure relates to recirculation of distal intestinal content. More specifically, the present disclosure relates to a system and process for recirculating distal intestinal content into the proximal small bowels of a subject for the treatment of short bowel syndrome (SBS).
Short bowel syndrome (SBS) is a condition in which the body is unable to absorb sufficient nutrients from foods eaten due to the shortened length of the small intestine. Maintenance of nutritional needs from regular enteral feeding is not possible for patients with SBS. Therefore, SBS patients require intravenous nutrition via total parenteral nutrition (TPN) for survival. If SBS patients do not receive TPN, the side effects of SBS can include intestinal failure associated liver disease (IFALD) and gut atrophy. However, there are long term complications associated with TPN. These complications include steatosis, cholestasis, cirrhosis, portal hypertension, and liver failure. In addition, gut mucosal atrophy and gut inflammation may still result in patients who undergo TPN. Thus, even with the current treatments, SBS patients have extensive morbidity and need intensive medical managements, with many such patients requiring a multi-visceral transplant for survival.
Various embodiments of the presently disclosed recirculation system are described herein with reference to the drawings, wherein:
Referring to
A surgical procedure may be performed on a subject with SBS to configure their digestive tract for distal intestinal content recirculation in order to effectively increase the operational length of the subject's small intestine. In particular, the procedure may rearrange and reconfigure the pathways through the subject's intestine to produce at least one recirculation loop within the intestine so that nutritional content flowing through the shortened small intestine is able to flow from a distal location in the small intestine back to a proximal location in the small intestine, one or more times, to provide additional opportunities for absorption of the nutritional content. In the illustrated embodiment, this nutritional loop consists wholly of the small intestine and does not include any additional bags, pumps, or tubing connected to the small intestine. Thus, the potential for skin breakdown, bag leakage, and/or pump occlusion caused by an external system is eliminated in the disclosed system 10.
Referring to
Referring to
Either before or after creating the anastomosis between the distal and proximal portions of the small intestine, an anastomosis can be created between the distal portion of the small intestine and the large intestine. For example, the proximal end of the large intestine that was disconnected from the distal end of the small intestine during the ostomy process can then be reconnected back to a distal side portion of the small intestine. In the illustrated embodiment, the anastomosis is created between the small bowels and the colon (i.e., small bowel/colonic anastomosis). Thus, in this embodiment, the anastomosis between the small intestine and the large intestine is located upstream from the anastomosis between the proximal and distal portions of the small intestine along the recirculation loop. Therefore, intestinal content recirculating through the small bowels will first pass the small bowel/colonic anastomosis before passing through the small bowl duodeno/jejunal anastomosis. In one embodiment, the anastomosis between the distal portion of the small intestine and the proximal end of the large intestine creates a bypass pathway whereby recirculated intestinal content can travel to the large intestine for further digestion.
Due to the nutrient rich nature of the intestinal content, and the design of the human digestive system, the body will direct the intestinal content through the recirculation loop (i.e., recirculation pathway), bypassing the large intestine, until the optimal amount of nutrients have been extracted from the intestinal content. For example, a section or chyme of intestinal content may recirculate through the recirculation several times to increase absorption. Once the nutrients have been extracted from the intestinal content and absorbed into the small intestine, the intestinal content will naturally flow into the large intestine along the bypass pathway. Thus, the recirculation procedure produces a physiologically powered and regulated recirculation system within the patient's body. As a result, adequate nutrient absorption is capable of being achieved in patients with short bowel syndrome.
In one embodiment, the recirculation system 10 includes at least one valve disposed along the recirculation loop for regulating the flow of nutritional content from the distal portion of the small intestine. Referring to
A second valve 12B may be provided at the anastomosis between the distal portion of the small intestines and the large intestine (i.e., colon). When the second valve 12B is open, nutritional content is allowed to flow from the distal portion of the small intestine into the large intestine thereby diverting the nutritional content away from the recirculation loop. However, when the second valve 12B is closed, nutritional content is prevented from entering the large intestines. In this case, the nutritional content will be directed into the proximal portion of the small intestine for recirculation through the small intestine.
In one embodiment, one or both of the valves 12A, 12B may comprise part of a controllable valve system whereby the opening and closing of the valve is controlled by an artificial valve system. Referring to
A mesh flange 16 (broadly, an anchor) may be attached to the balloon valve 14 and configured to secure the balloon valve at the anastomosis. A valve catheter 18 may be placed in fluid communication with an interior space of the balloon valve 14 and extend from the balloon valve to an actuator 20. The valve catheter 18 is configured to extend subcutaneously from the balloon valve 14 in the intestine to an exterior of the patient for connecting to the actuator 20 at a location externally of the body. A section of the valve catheter 18 located externally of the body may be secured to the patient's skin by a flange 22. In the illustrated embodiment, the actuator 20 comprises a pump configured for inflating and deflating the balloon valve 14. For example, the pump 20 may deliver pressurized fluid through the valve catheter 18 into the interior of the balloon valve 14 to inflate the balloon. Inflation of the balloon valve 14 will expand the size of the balloon causing the balloon to engage the walls of the intestine preventing fluid in the intestine from passing the balloon. Therefore, inflating the balloon valve 14 functions to “close” the balloon valve. Conversely, the pump 20 is operable to draw fluid out of the balloon valve 14 to deflate the balloon. Deflation of the balloon valve 14 will decrease the size of the balloon causing the balloon to be disengaged from the walls of the intestine permitting fluid to flow past the balloon. Therefore, deflating the balloon valve 14 functions to “open” the balloon valve. Operation of the pump 20 can be controlled by a controller of the pump. Thus, the openings and closing of the valves may be accomplished automatically using the pump programing. Other types of controllable valve systems are also envisioned without departing from the scope of the disclosure. For example, pneumatic, magnetic, mechanical, and sensor valve systems may be used. In one embodiment, the controllable valve system may include a sensor configured to determine flux to control the opening and closing of the valve.
Referring to
The study found that piglets given TPN resulted in cholestatic liver injury while the piglets in the RDIC group had significantly reduced cholestasis markers compared to SBS.
Referring to
Finally, and with reference to
Persons skilled in the art will understand that the systems and methods specifically described herein and illustrated in the accompanying drawings are non-limiting exemplary embodiments. It is envisioned that the elements and features illustrated or described in connection with one exemplary embodiment may be combined with the elements and features of another without departing from the scope of the present disclosure. As well, one skilled in the art will appreciate further features and advantages of the disclosure based on the above-described embodiments. Accordingly, the disclosure is not to be limited by what has been particularly shown and described, except as indicated by the appended claims.
This application claims priority to U.S. provisional application Ser. No. 63/587,781, filed on Oct. 4, 2023, the disclosure of which is hereby incorporated by reference in its entirety.
This invention was made with government support under Grant Nos. RO1 DK131136 and R21 AI169487 from the National Institute of Health (NIH). The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
63587781 | Oct 2023 | US |